Home/Filings/4/0001140361-21-033112
4//SEC Filing

Cove Investors II, LLC 4

Accession 0001140361-21-033112

CIK 0001628945other

Filed

Sep 29, 8:00 PM ET

Accepted

Sep 30, 4:38 PM ET

Size

16.2 KB

Accession

0001140361-21-033112

Insider Transaction Report

Form 4
Period: 2021-09-28
Day Kelly P.
10% Owner
Transactions
  • Conversion

    Common Stock

    2021-09-28+6,721,71412,377,254 total(indirect: See Footnote)
  • Conversion

    Series C-1 Preferred Stock

    2021-09-28273,0820 total(indirect: See Footnote)
    Common Stock (273,082 underlying)
  • Conversion

    Series B Preferred Stock

    2021-09-285,358,4520 total(indirect: See Footnote)
    Common Stock (5,358,452 underlying)
  • Conversion

    Series A Preferred Stock

    2021-09-281,090,1800 total(indirect: See Footnote)
    Common Stock (1,090,180 underlying)
Transactions
  • Conversion

    Common Stock

    2021-09-28+6,721,71412,377,254 total(indirect: See Footnote)
  • Conversion

    Series A Preferred Stock

    2021-09-281,090,1800 total(indirect: See Footnote)
    Common Stock (1,090,180 underlying)
  • Conversion

    Series B Preferred Stock

    2021-09-285,358,4520 total(indirect: See Footnote)
    Common Stock (5,358,452 underlying)
  • Conversion

    Series C-1 Preferred Stock

    2021-09-28273,0820 total(indirect: See Footnote)
    Common Stock (273,082 underlying)
Transactions
  • Conversion

    Series B Preferred Stock

    2021-09-285,358,4520 total(indirect: See Footnote)
    Common Stock (5,358,452 underlying)
  • Conversion

    Series C-1 Preferred Stock

    2021-09-28273,0820 total(indirect: See Footnote)
    Common Stock (273,082 underlying)
  • Conversion

    Series A Preferred Stock

    2021-09-281,090,1800 total(indirect: See Footnote)
    Common Stock (1,090,180 underlying)
  • Conversion

    Common Stock

    2021-09-28+6,721,71412,377,254 total(indirect: See Footnote)
Footnotes (6)
  • [F1]On September 28, 2021, the Series A Preferred Stock automatically converted into Common Stock on a one-to-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
  • [F2]On September 28, 2021, the Series B Preferred Stock automatically converted into Common Stock on a one-to-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
  • [F3]On September 28, 2021, the Series C-1 Preferred Stock automatically converted into Common Stock on a one-to-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
  • [F4]Includes 6,745,720 shares held directly by Cove Investors I, LLC ("Cove I") and 5,631,534 shares held directly by Cove Investors II, LLC ("Cove II"). Kelly Day is the member of Cove I and Cove II with authority to direct the voting interests of Cove I and Cove II with respect to shares held by Cove I and Cove II, respectively, and as a result may be deemed to have beneficial ownership of such shares.
  • [F5]The shares are held directly by Cove I. Kelly Day is the member of Cove I with authority to direct the voting interests of Cove I with respect to shares held by Cove I, and as a result may be deemed to have beneficial ownership of such shares.
  • [F6]The shares are held directly by Cove II. Kelly Day is the member of Cove II with authority to direct the voting interests of Cove II with respect to shares held by Cove II, and as a result may be deemed to have beneficial ownership of such shares.

Issuer

Cue Health Inc.

CIK 0001628945

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001874136

Filing Metadata

Form type
4
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 4:38 PM ET
Size
16.2 KB